NICOLE MITCHELL: Open Payments
NPI 1639474059 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$895 in 50 payments from 11 companies in 2025. Trend: 2023 $2,395 · 2024 $947 · 2025 $895
Food & beverage: $895
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $177 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $152 |
| Phathom Pharmaceuticals, Inc. | 14 | $127 |
| PFIZER INC. | 6 | $123 |
| ABBVIE INC. | 5 | $104 |
| Regeneron Healthcare Solutions, Inc. | 5 | $91 |
| EVOKE PHARMA, INC. | 2 | $33 |
| Ardelyx, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| QOL Medical, LLC | 1 | $22 |
Products named: DUPIXENT, XIFAXAN, VOQUEZNA, XELJANZ, CREON, VELSIPITY, GIMOTI, IBSRELA.
Industry payments across MD — which companies pay providers there.
